BD Becton, Dickinson and Company NYSE: BDX , a leading global medical technology company, today announced the global commercial release of BDR Research Cloud 7.0, furthering the companys AI roadmap while strengthening its leadership in flow cytometry and life sciences research. The new release introduces BD Horizon Panel Maker, an AI-powered tool for automated panel design - one of the most critical steps across immunology and cancer research experiments designed to help ensure the quality and usability of scientific results.
BDR Research Cloud version 7.0 provides scientists with a cloud-based ecosystem for flow cytometry that supports collaboration between team members, streamlines workflows, and manages laboratory operations, from instrument health to purchasing and managing reagents.
The new BD Horizon Panel Maker tool leverages a novel, sophisticated AI algorithm to generate optimized panel recommendations within seconds. Researchers can create panels using custom experimental inputs or draw from curated databases of validated options. Poorly designed panels can lead to unusable, unreliable or irreproducible data, resulting in wasted time, samples, and reagents. By providing automated recommendations and integrated visualization tools, like comparison tables and complexity scores, BD Horizon Panel Maker enables researchers to more efficiently evaluate and select the panels best suited for their experiments.
